doi: 10.3389/fendo.2026.1784709 Received 10 January 2026 Revised 30 January 2026 Accepted 30 January 2026 Published 18 February 2026 Volume 17 - 2026 Edited by Marcia Hiriart, Universidad Nacional Autonoma de Mexico, Mexico Reviewed by Jialin Fan, Rutgers, The State University of New Jersey, United States Kei Shing Ng, The University of Hong Kong, Hong Kong SAR, China Updates Copyright 2026 Liu, Ren, Zhang and Ma
Tramadol will be PROHIBITED IN-COMPETITION As of January 1, 2024, tramadol is prohibited in-competition* in the class of S7
These results underscore the need for future studies with larger sample sizes, and measurements of potential confounders, especially weight and biomarkers (i.e., HbA1c) to confirm our findings
[3] , [4] Achievement of target glucose levels, especially in the early years after T2D diagnosis, reduces the incidence and progression of microvascular complications and, in the long term (more than 10 years), is associated with reduced CV outcomes
Fish LH, Schwartz HL, Cavanaugh J, et al
Longer-term safety is still being studied because the molecule is not yet approved